These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 7714770

  • 1. Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo.
    Cuadra G, Giacobini E.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):230-40. PubMed ID: 7714770
    [Abstract] [Full Text] [Related]

  • 2. Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo.
    Cuadra G, Giacobini E.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):228-36. PubMed ID: 7562554
    [Abstract] [Full Text] [Related]

  • 3. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
    Cuadra G, Summers K, Giacobini E.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):277-84. PubMed ID: 7913496
    [Abstract] [Full Text] [Related]

  • 4. Effects of MF-268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex.
    Zhu XD, Cuadra G, Brufani M, Maggi T, Pagella PG, Williams E, Giacobini E.
    J Neurosci Res; 1996 Jan 01; 43(1):120-6. PubMed ID: 8838583
    [Abstract] [Full Text] [Related]

  • 5. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A.
    Brain Res Bull; 2006 Mar 31; 69(2):204-13. PubMed ID: 16533671
    [Abstract] [Full Text] [Related]

  • 6. Second generation cholinesterase inhibitors: effect of (L)-huperzine-A on cortical biogenic amines.
    Zhu XD, Giacobini E.
    J Neurosci Res; 1995 Aug 15; 41(6):828-35. PubMed ID: 7500384
    [Abstract] [Full Text] [Related]

  • 7. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
    Liang YQ, Tang XC.
    Acta Pharmacol Sin; 2006 Sep 15; 27(9):1127-36. PubMed ID: 16923332
    [Abstract] [Full Text] [Related]

  • 8. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P, Flore G, Pani L, Gessa GL.
    Mol Psychiatry; 2001 Nov 15; 6(6):657-64. PubMed ID: 11673793
    [Abstract] [Full Text] [Related]

  • 9. Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: a microdialysis study in freely moving rats.
    Chen NH, Reith ME.
    J Pharmacol Exp Ther; 1994 Dec 15; 271(3):1597-610. PubMed ID: 7996474
    [Abstract] [Full Text] [Related]

  • 10. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
    Acquas E, Wilson C, Fibiger HC.
    J Pharmacol Exp Ther; 1997 Apr 15; 281(1):360-8. PubMed ID: 9103518
    [Abstract] [Full Text] [Related]

  • 11. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
    Gobert A, Di Cara B, Cistarelli L, Millan MJ.
    J Pharmacol Exp Ther; 2003 Apr 15; 305(1):338-46. PubMed ID: 12649387
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
    Dennis T, L'Heureux R, Carter C, Scatton B.
    J Pharmacol Exp Ther; 1987 May 15; 241(2):642-9. PubMed ID: 3033221
    [Abstract] [Full Text] [Related]

  • 14. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
    de Boer TH, Nefkens F, van Helvoirt A, van Delft AM.
    J Pharmacol Exp Ther; 1996 May 15; 277(2):852-60. PubMed ID: 8627567
    [Abstract] [Full Text] [Related]

  • 15. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
    Prus AJ, Huang M, Li Z, Dai J, Meltzer HY.
    Brain Res; 2007 Dec 12; 1184():354-64. PubMed ID: 17988654
    [Abstract] [Full Text] [Related]

  • 16. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
    Jackisch R, Huang HY, Reimann W, Limberger N.
    J Pharmacol Exp Ther; 1993 Feb 12; 264(2):889-98. PubMed ID: 8094757
    [Abstract] [Full Text] [Related]

  • 17. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.
    Gresch PJ, Sved AF, Zigmond MJ, Finlay JM.
    J Neurochem; 1995 Jul 12; 65(1):111-6. PubMed ID: 7790854
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1998 Sep 12; 125(1):175-85. PubMed ID: 9776358
    [Abstract] [Full Text] [Related]

  • 19. Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.
    Camacho F, Smith CP, Vargas HM, Winslow JT.
    Psychopharmacology (Berl); 1996 Apr 12; 124(4):347-54. PubMed ID: 8739550
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.